{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:50:28Z","timestamp":1790416228218,"version":"4.1.0"},"reference-count":24,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Clin Med Insights Endocrinol Diabetes"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Semaglutide, a Glucagon-like peptide 1 (GLP-1) is highly effective as an anti-diabetic medication along with additional benefits of significant reduction in cardiovascular events and weight.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>There is a lack of reliable evidence confirming the benefits of Semaglutide in the Pakistani cohort. Our study aims to ascertain the efficacy of Semaglutide in the Pakistani cohort and patient satisfaction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>An ambi-directional cohort study was conducted from August 2022 to January 2023 at The Aga Khan University Hospital, Karachi, Pakistan. A chart review was done for all patients with Type 2 diabetes who were prescribed Semaglutide, and baseline data was recorded. Patients were followed prospectively in the endocrinology clinics after at least 3\u2009months for the change in HbA1c, BMI, adverse effects profile, treatment satisfaction questionnaire for medications (TSQM-9) and medication effect score. Mean\u2009+\u2009STD or median with IQR were computed for continuous data, while categorical variables and percentages were measured. The association between variables was assessed by applying the chi-square test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 112 patients were recruited who took the medication for at least 3\u2009months. The mean age of the patients was 50.9\u2009\u00b1\u200910.5\u2009years with 51.2% females. The mean difference in weight, body mass index, fasting blood glucose, HbA1c, and medication effect score were decreasing from baseline to follow-up (\u22124.0 kg, \u22121.5 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      , \u221223.1 mg\/dl, \u22121.2%, \u22120.4) respectively. A decrease in appetite was reported in 72.7% of the participants. The major adverse effects observed were dyspepsia (21.4%) followed by nausea (20.5%) and constipation (19.6%). Medication was discontinued in 9.8% of patients due to gastrointestinal side effects. The majority (72.3%) of patients were satisfied with their medication.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Semaglutide is effective in reducing HbA1c and weight in Pakistani population with measurable tolerability and patient satisfaction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/11795514231213568","type":"journal-article","created":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T04:07:26Z","timestamp":1700798846000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":8,"title":["Efficacy and Tolerability of Semaglutide in Patients With Type-2 Diabetes Mellitus: Experience of a Tertiary Care Hospital, Pakistan"],"prefix":"10.1177","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-2960-0452","authenticated-orcid":false,"given":"Maria","family":"Wajid","sequence":"first","affiliation":[{"name":"Section of Endocrinology, Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadia","family":"Sattar","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Khalid","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Qamar","family":"Masood","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Department of Medicine, The Aga Khan University Hospital, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"bibr1-11795514231213568","doi-asserted-by":"publisher","DOI":"10.2991\/jegh.k.191028.001"},{"key":"bibr2-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2010.01256.x"},{"key":"bibr3-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1159\/000480525"},{"key":"bibr4-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21107"},{"key":"bibr5-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2012.11.009"},{"key":"bibr6-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2020.1776108"},{"key":"bibr7-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607141"},{"key":"bibr8-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz072"},{"key":"bibr9-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-021-01015-z"},{"key":"bibr10-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1080\/14740338.2020.1772230"},{"key":"bibr11-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1900\/RDS.2014.11.202"},{"key":"bibr12-11795514231213568","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.36.3.358"},{"key":"bibr13-11795514231213568","volume":"12","author":"Zameer R","year":"2020","journal-title":"Cureus"},{"key":"bibr14-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1177\/1742395319884096"},{"key":"bibr15-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-2-12"},{"key":"bibr16-11795514231213568","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15050947"},{"key":"bibr17-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00070"},{"key":"bibr18-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14117"},{"key":"bibr19-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcd.2021.06.008"},{"key":"bibr20-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(22)00497-1"},{"key":"bibr21-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.316101"},{"key":"bibr22-11795514231213568","doi-asserted-by":"crossref","unstructured":"Villela R, Correa R. Semaglutide 2.4 mg: The Latest GLP-1RA Approved for Obesity. BMJ Publishing Group Limited; 2022:3-4.","DOI":"10.1136\/jim-2021-002227"},{"key":"bibr23-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-017-0532-6"},{"key":"bibr24-11795514231213568","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0268403"}],"container-title":["Clinical Medicine Insights: Endocrinology and Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11795514231213568","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/11795514231213568","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/11795514231213568","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:00:05Z","timestamp":1777406405000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/11795514231213568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":24,"alternative-id":["10.1177\/11795514231213568"],"URL":"https:\/\/doi.org\/10.1177\/11795514231213568","relation":{},"ISSN":["1179-5514","1179-5514"],"issn-type":[{"value":"1179-5514","type":"print"},{"value":"1179-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"article-number":"11795514231213568"}}